|
T45.3X6D Underdosing of enzymes, subsequent encounter |
|
T45.4X1D Poisoning by iron and its compounds, accidental (unintentional), subsequent encounter |
|
T45.4X2D Poisoning by iron and its compounds, intentional self-harm, subsequent encounter |
|
T45.4X3D Poisoning by iron and its compounds, assault, subsequent encounter |
|
T45.4X4D Poisoning by iron and its compounds, undetermined, subsequent encounter |
|
T45.4X5D Adverse effect of iron and its compounds, subsequent encounter |
|
T45.4X6D Underdosing of iron and its compounds, subsequent encounter |
|
T45.511D Poisoning by anticoagulants, accidental (unintentional), subsequent encounter |
|
T45.512D Poisoning by anticoagulants, intentional self-harm, subsequent encounter |
|
T45.513D Poisoning by anticoagulants, assault, subsequent encounter |
|
T45.514D Poisoning by anticoagulants, undetermined, subsequent encounter |
|
T45.515D Adverse effect of anticoagulants, subsequent encounter |
|
T45.516D Underdosing of anticoagulants, subsequent encounter |
|
T45.521D Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter |
|
T45.522D Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter |
|
T45.523D Poisoning by antithrombotic drugs, assault, subsequent encounter |
|
T45.524D Poisoning by antithrombotic drugs, undetermined, subsequent encounter |
|
T45.525D Adverse effect of antithrombotic drugs, subsequent encounter |
|
T45.526D Underdosing of antithrombotic drugs, subsequent encounter |
|
T45.601D Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter |
|
T45.602D Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter |
|
T45.603D Poisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter |
|
T45.604D Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter |
|
T45.605D Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter |
|
T45.606D Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter |
|
T45.611D Poisoning by thrombolytic drug, accidental (unintentional), subsequent encounter |
|
T45.612D Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter |
|
T45.613D Poisoning by thrombolytic drug, assault, subsequent encounter |
|
T45.614D Poisoning by thrombolytic drug, undetermined, subsequent encounter |
|
T45.615D Adverse effect of thrombolytic drugs, subsequent encounter |
|
T45.616D Underdosing of thrombolytic drugs, subsequent encounter |
|
T45.621D Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter |
|
T45.622D Poisoning by hemostatic drug, intentional self-harm, subsequent encounter |
|
T45.623D Poisoning by hemostatic drug, assault, subsequent encounter |
|
T45.624D Poisoning by hemostatic drug, undetermined, subsequent encounter |
|
T45.625D Adverse effect of hemostatic drug, subsequent encounter |
|
T45.626D Underdosing of hemostatic drugs, subsequent encounter |
|
T45.691D Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter |
|
T45.692D Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter |
|
T45.693D Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter |
|
T45.694D Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter |
|
T45.695D Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter |
|
T45.696D Underdosing of other fibrinolysis-affecting drugs, subsequent encounter |
|
T45.7X1D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter |
|
T45.7X2D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter |
|
T45.7X3D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter |
|
T45.7X4D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter |
|
T45.7X5D Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter |
|
T45.7X6D Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter |
|
T45.8X1D Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter |
|
T45.8X2D Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter |
|
T45.8X3D Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter |
|
T45.8X4D Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter |
|
T45.8X5D Adverse effect of other primarily systemic and hematological agents, subsequent encounter |
|
T45.8X6D Underdosing of other primarily systemic and hematological agents, subsequent encounter |
|
T45.91XD Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter |
|
T45.92XD Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter |
|
T45.93XD Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter |
|
T45.94XD Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter |
|
T45.95XD Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter |
|
T45.96XD Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter |
|
T46.0X1D Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter |
|
T46.0X2D Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter |
|
T46.0X3D Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter |
|
T46.0X4D Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter |
|
T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter |
|
T46.0X6D Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter |
|
T46.1X1D Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter |
|
T46.1X2D Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter |
|
T46.1X3D Poisoning by calcium-channel blockers, assault, subsequent encounter |
|
T46.1X4D Poisoning by calcium-channel blockers, undetermined, subsequent encounter |
|
T46.1X5D Adverse effect of calcium-channel blockers, subsequent encounter |
|
T46.1X6D Underdosing of calcium-channel blockers, subsequent encounter |
|
T46.2X1D Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter |
|
T46.2X2D Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter |
|
T46.2X3D Poisoning by other antidysrhythmic drugs, assault, subsequent encounter |
|
T46.2X4D Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter |
|
T46.2X5D Adverse effect of other antidysrhythmic drugs, subsequent encounter |
|
T46.2X6D Underdosing of other antidysrhythmic drugs, subsequent encounter |
|
T46.3X1D Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter |
|
T46.3X2D Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter |
|
T46.3X3D Poisoning by coronary vasodilators, assault, subsequent encounter |
|
T46.3X4D Poisoning by coronary vasodilators, undetermined, subsequent encounter |
|
T46.3X5D Adverse effect of coronary vasodilators, subsequent encounter |
|
T46.3X6D Underdosing of coronary vasodilators, subsequent encounter |
|
T46.4X1D Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter |
|
T46.4X2D Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter |
|
T46.4X3D Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter |
|
T46.4X4D Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter |
|
T46.4X5D Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter |
|
T46.4X6D Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter |
|
T46.5X1D Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter |
|
T46.5X2D Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter |
|
T46.5X3D Poisoning by other antihypertensive drugs, assault, subsequent encounter |
|
T46.5X4D Poisoning by other antihypertensive drugs, undetermined, subsequent encounter |
|
T46.5X5D Adverse effect of other antihypertensive drugs, subsequent encounter |
|
T46.5X6D Underdosing of other antihypertensive drugs, subsequent encounter |
|
T46.6X1D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter |
|
T46.6X2D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter |
|
T46.6X3D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter |
